Replies to post #229208 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

It is going to be Rett Syndrome IMO..
Dr K is running silent.. but..

We should have RS top line ready by mid year..

Based on early positive Glutamate reduction feel good about this process..that would be marketing approval..that should unlock FDA Early review.. that should unlock $80,000,000 .. and start revenue process..

So 6-9 months out..